Hinova Pharma

company

About

Hinova Pharma is a pharmaceutical company.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
$40M
Industries
Health Care,Pharmaceutical
Founded date
Jan 1, 2013
Number Of Employee
101 - 250
Operating Status
Active

Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$40M ¥1B
Hinova Pharma has raised a total of $40M ¥1B in funding over 2 rounds. Their latest funding was raised on Oct 6, 2020 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 6, 2020 Series C ¥1B 1 Detail
Sep 1, 2020 Series D 1 Detail
Jul 31, 2019 Series B $40M 3 Detail

Investors

Number of Lead Investors
Number of Investors
5
Hinova Pharma is funded by 5 investors. Sinopharm-CICC and Innovitalize Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Sinopharm-CICC Series C
Innovitalize Capital Series D
Chengdu Dingjian New Material Partnership Series B
Silicon Valley Torch Fund Series B
Prosper Capital Series B